Financials
- Market Capitalization 1.6 B
- Employee 367
- Founded 2016
- CEO Marianne De Backer
- Website www.vir.bio
- Headquarter Delaware, United States
- FIGI BBG00H2QQ8T5
- Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-2.86
주가매출액비율
18.95
Related tickers
| # | 이름 | 가격 | 24h % | 7d % | 1M % | 1Y % | 마켓 캡 | 이전 7일 | |
|---|---|---|---|---|---|---|---|---|---|
| 2136 | TSHA Taysha Gene Therapies, Inc. - Common Stock | 5.70 USD | +5.95% | -11.76% | -5.00% | +126.19% | 1.64 B USD | ||
| 2145 | INVA Innoviva, Inc. - Common Stock | 21.74 USD | -2.12% | -2.29% | -5.35% | +22.00% | 1.60 B USD | ||
| 2147 | ABSI Absci Corporation - Common Stock | 10.23 USD | +0.20% | -6.66% | +40.33% | +288.97% | 1.59 B USD | ||
| 2159 | SEPN Septerna, Inc. - Common Stock | 34.54 USD | +0.52% | -2.35% | -3.87% | +56.93% | 1.56 B USD |